Profiel
Dr. Michael Häggman is an Independent Director at Prostatype Genomics AB, an Associate Professor-Urology at Uppsala University Hospital, a Deputy Director at Kardinaltalet AB and a General Partner at Skrotum Kommanditbolag.
He is on the Board of Directors at Prostatype Genomics AB and Chundsell Medicals AB.
Actieve functies van Michael Häggman
| Bedrijven | Functie | Begin |
|---|---|---|
| PROSTATYPE GENOMICS AB | Directeur/Bestuurslid | 01-01-2018 |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Develops and markets novel molecular diagnostics for the treatment of cancer | Directeur/Bestuurslid | - |
Kardinaltalet AB
Kardinaltalet AB Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Corporate Officer/Principal | - |
Skrotum Kommanditbolag | Corporate Officer/Principal | - |
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Health Services |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Develops and markets novel molecular diagnostics for the treatment of cancer | Health Technology |
Kardinaltalet AB
Kardinaltalet AB Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Commercial Services |
Prostatype Genomics AB
Prostatype Genomics AB Medical SpecialtiesHealth Technology Develops, manufactures and markets prognostic genetic test prostatype equipment | Health Technology |
Skrotum Kommanditbolag |
















